https://www.selleckchem.com/products/vtx-27.html
18, 95% CI 0.06-0.57, 0.01 and HR=0.17, 95% CI 0.06-0.54, 0.01). Among patients with DAC, treatment with RP was associated with better survival outcomes in comparison with RT. Patients with DAC in the middle tertile of the age and with lower tertile PSA level benefited the most from RP. Among patients with DAC, treatment with RP was associated with better survival outcomes in comparison with RT. Patients with DAC in the middle tertile of the age and with lower tertile PSA level benefited the most from RP. Urinary tract infection